文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

单肺通气期间个体化围手术期开放肺通气策略(iPROVE-OLV):一项多中心、随机、对照临床试验

Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial.
PubMed 文献 · Lancet Respir Med · 2023-12-05
一句话结论在接受单肺通气的肺切除术患者中,个体化开放肺通气策略(iOLA)较标准肺保护通气降低术后7天内严重肺部并发症风险(6% vs 15%,RR 0.39)。

该多中心随机对照试验在西班牙、意大利、土耳其、埃及和厄瓜多尔25家医院纳入1380例接受单肺通气的开胸或电视辅助胸腔镜手术成人患者,随机分入iOLA组或标准肺保护通气组。iOLA包括40 cm H2O吸气末压力肺复张、以最佳呼吸系统顺应性滴定个体化PEEP及术后经鼻高流量氧疗;对照组术中PEEP 4 cm H2O联合术后常规氧疗。最终分析1308例,iOLA组术后7天内严重肺部并发症复合终点发生率6%(40/670),显著低于对照组的15%(97/638),RR 0.39(95%CI 0.28-0.56),绝对风险差-9.23%(95%CI -12.55至-5.92)。复张操作相关不良事件5例。

要点

  • 在接受单肺通气的肺切除术患者中,iOLA组术后7天内严重肺部并发症复合终点发生率为6%(40/670),标准肺保护通气组为15%(97/638),RR 0.39(95%CI 0.28-0.56)。
  • iOLA组绝对风险差为-9.23%(95%CI -12.55至-5.92),即每治疗约11例可避免1例严重肺部并发症(由绝对风险差推算)。
  • iOLA方案:40 cm H2O吸气末压力肺复张,随后以最佳呼吸系统顺应性滴定个体化PEEP,术后采用经鼻高流量氧疗。
  • 标准肺保护通气方案:术中PEEP 4 cm H2O联合术后常规氧疗。
  • 复张操作相关不良事件报告5例。

适用人群与场景

  • 年龄≥18岁、计划在单肺通气下接受开胸或电视辅助胸腔镜手术的成人患者。
  • 来自西班牙、意大利、土耳其、埃及和厄瓜多尔25家参与医院。
  • 最终分析纳入1308例合格患者:iOLA组670例(434男、233女、3例性别数据缺失),标准肺保护通气组638例(395男、237女、6例性别数据缺失)。

处置流程与药物剂量

  • iOLA组:实施肺泡复张操作至吸气末压力40 cm H2O,随后以最佳呼吸系统顺应性滴定个体化PEEP,术后采用经鼻高流量氧疗个体化呼吸支持。
  • 标准肺保护通气组:术中联合应用PEEP 4 cm H2O,术后采用常规氧疗。

研究设计与关键结果

  • 研究类型:多中心、随机、对照临床试验;25家参与医院;纳入1380例,最终分析1308例;按中心分层、1:1在线随机分配;意向性分析。
  • 主要终点:术后7天内严重肺部并发症复合终点(包括需支气管镜检查的肺不张、严重呼吸衰竭、对侧气胸、早期拔管失败需持续气道正压、无创通气、有创机械通气或再插管抢救、急性呼吸窘迫综合征、肺部感染、支气管胸膜瘘和脓胸)。
  • iOLA组主要终点发生40例(6%),标准肺保护通气组97例(15%),RR 0.39(95%CI 0.28-0.56),绝对风险差-9.23%(95%CI -12.55至-5.92)。
  • 复张操作相关不良事件报告5例。
  • 研究注册号ClinicalTrials.gov NCT03182062,已完成。

证据类型、等级与局限

  • 证据类型:多中心随机对照临床试验。
  • 由于试验设置,手术室和术后恢复室常规监测数据未设盲;24小时数据由对分组设盲的研究者采集。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于接受单肺通气的肺切除术成人患者,iOLA策略(40 cm H2O肺复张、以最佳呼吸系统顺应性滴定个体化PEEP、术后经鼻高流量氧疗)较标准肺保护通气(PEEP 4 cm H2O联合术后常规氧疗)可降低术后7天内严重肺部并发症风险(6% vs 15%,RR 0.39)。
  • 复张操作相关不良事件报告5例,实施肺复张时需注意监测。

指南或共识出处

  • iPROVE-OLV试验,发表于Lancet Respir Med,注册号NCT03182062。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: It is uncertain whether individualisation of the perioperative open-lung approach (OLA) to ventilation reduces postoperative pulmonary complications in patients undergoing lung resection. We compared a perioperative individualised OLA (iOLA) ventilation strategy with standard lung-protective ventilation in patients undergoing thoracic surgery with one-lung ventilation.

METHODS: This multicentre, randomised controlled trial enrolled patients scheduled for open or video-assisted thoracic surgery using one-lung ventilation in 25 participating hospitals in Spain, Italy, Turkey, Egypt, and Ecuador. Eligible adult patients (age ≥18 years) were randomly assigned to receive iOLA or standard lung-protective ventilation. Eligible patients (stratified by centre) were randomly assigned online by local principal investigators, with an allocation ratio of 1:1. Treatment with iOLA included an alveolar recruitment manoeuvre to 40 cm H2O of end-inspiratory pressure followed by individualised positive end-expiratory pressure (PEEP) titrated to best respiratory system compliance, and individualised postoperative respiratory support with high-flow oxygen therapy. Participants allocated to standard lung-protective ventilation received combined intraoperative 4 cm H2O of PEEP and postoperative conventional oxygen therapy. The primary outcome was a composite of severe postoperative pulmonary complications within the first 7 postoperative days, including atelectasis requiring bronchoscopy, severe respiratory failure, contralateral pneumothorax, early extubation failure (rescue with continuous positive airway pressure, non-invasive ventilation, invasive mechanical ventilation, or reintubation), acute respiratory distress syndrome, pulmonary infection, bronchopleural fistula, and pleural empyema. Due to trial setting, data obtained in the operating and postoperative rooms for routine monitoring were not blinded. At 24 h, data were acquired by an investigator blinded to group allocation. All analyses were performed on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov, NCT03182062, and is complete.

FINDINGS: Between Sept 11, 2018, and June 14, 2022, we enrolled 1380 patients, of whom 1308 eligible patients (670 [434 male, 233 female, and three with missing data] assigned to iOLA and 638 [395 male, 237 female, and six with missing data] to standard lung-protective ventilation) were included in the final analysis. The proportion of patients with the composite outcome of severe postoperative pulmonary complications within the first 7 postoperative days was lower in the iOLA group compared with the standard lung-protective ventilation group (40 [6%] vs 97 [15%], relative risk 0·39 [95% CI 0·28 to 0·56]), with an absolute risk difference of -9·23 (95% CI -12·55 to -5·92). Recruitment manoeuvre-related adverse events were reported in five patients.

INTERPRETATION: Among patients subjected to lung resection under one-lung ventilation, iOLA was associated with a reduced risk of severe postoperative pulmonary complications when compared with conventional lung-protective ventilation.

FUNDING: Instituto de Salud Carlos III and the European Regional Development Funds.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Ferrando C, Carramiñana A, Piñeiro P, et al. Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2023. PMID: 38065200. doi:10.1016/S2213-2600(23)00346-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。